Abemaciclib news

All news on Abemaciclib (also known as Verzenio): plants, production capacities, investments and involved companies.

12 December 2025

Lilly's Inluriyo™ Shows Efficacy in ER+, HER2- Breast Cancer

Inluriyo™ improves survival in ER+, HER2- breast cancer, both alone and with abemaciclib, extending time to chemotherapy and showing durable benefits across patient groups.

Who will be producing Abemaciclib in the future?

Find out with chemXplore Alpha

Learn more